Skip to content

Wockhardt and Serum Institute of India tie up in UK

The joint venture includes a new facility set up at Wrexham, North Wales to make more doses for the markets across Europe and the UK.

Mumbai-based pharmaceutical company, Wockhardt and a branch of Serum Institute of India (SII), Serum Life Sciences, entered into a partnership to make 150 million doses of SII vaccines in Wockhardt’s UK plant.

A new facility set up has been planned at Wrexham in North Wales. The two companies initiated this joint venture with an equal investment from both sides.

This post is for paying subscribers only


Already have an account? Log in